Veterinary stem cell therapy is an exciting emerging discipline within veterinary medicine and surgery. Knowledge is growing at an exponential rate. This can leave us feeling overwhelmed by the sheer volume of scientific material constantly being produced. There is a need for a clear source of up-to-date, trustworthy, and accurate information on veterinary stem cell therapy without any hype. Welcome to vet stem cell hub. This site is for veterinary professionals who wish to learn more about stem cell therapies. VSCH is a guide only, it does not replace the essential requirement for examination of a patient by a qualified veterinary clinician. VSCH may refer to or mention various products or services, this is not necessarily an endorsement of those products or services. VSCH seeks to disseminate information in a responsible way. We do not comment on individual cases as all clinical judgements are the responsibility of the attending veterinary clinician. While every effort is made to verify the accuracy of the information presented, the field is advancing rapidly so veterinary professionals must use their own clinical judgement when managing their patients. Thank you for visiting VSCH.
Ground breaking!
Today, we approved an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy for the treatment of steroid-refractory acute graft-versus-host disease in pediatric patients 2 months of age and older. https://lnkd.in/eH63UdNn
Vet Stem Cell Hub reposted this
Brook received #VetStem Cell Therapy in conjunction with surgery for a torn cruciate ligament. Her #veterinary surgeon, Dr. Jeff Christiansen of Superior Veterinary Surgical Solutions has performed well over 300 #stemcell procedures! Check out Brook's VetStem success story at the link below. #stemcells #regenerativemedicine
Fantastic work Prof Too’s team!
From a small town in Malaysia to pioneering "mini bombers" and "cleaners" for aggressive cancer treatment, Dr Sarah ho's journey with AGeM Bio is a reminder that breakthroughs often come with persistence. As Prof Too Heng-Phon, her mentor, aptly puts it: "There are many entrepreneurs who started believing in something that didn't work. But we should clap our hands and say, bravo—you dared to try." 👏 Together, AGEM Bio Pte. Ltd. is developing precision therapies for aggressive cancers, offering a new approach to one of medicine's toughest challenges. 📖 Read more here: https://lnkd.in/gQqPYmWB Jun Yung Woo Ria Xavier Goie Jian Yi Gerald
Great post!
"Conservative" or "Operative"? In clinical practice, we often use the terms conservative and operative to categorize treatment approaches. But I feel it’s oversimplified. Here’s the reality: • Operative treatments can be conservative or non-conservative. • Similarly, non-operative treatments can also be conservative or non-conservative. For example: • Arthroscopic repair of a meniscus tear is an "operative-conservative" treatment because it preserves knee function. • Treating knee osteoarthritis with intra-articular steroids is “non-operative-non-conservative” because it doesn’t address the root cause or restore tissue health. • On the other hand, orthobiologics treatments for knee osteoarthritis are “non-operative-conservative”, as they aim to preserve and restore joint integrity. • But, orthobiologics treatment to treat avascular necrosis (AVN) is “operative-conservative” treatment. The list goes on, but the key takeaway is that we can’t simply divide treatments into “conservative” or “operative.” This perspective allows us to focus on preserving function and tissue integrity, aligning with a patient-centred approach. What are your thoughts on these? Let’s discuss.
Vet Stem Cell Hub reposted this
No te pierdas esta noche el emocionante V Webinario de la Academia Española de Medicina Regenerativa (#AEMR)! Bajo el título: "Avances en Ingeniería Tisular en el Aparato Locomotor: presente y aplicaciones prácticas", este evento es una oportunidad única para explorar el futuro de la medicina regenerativa con los mejores expertos. 🗓️ Fecha: Jueves 12 Diciembre 2024 (21h España) (¡Reserva tu plaza!) 👨⚕️ Ponente destacado: Dr. Jesús Ordoño, PhD miembro de la Sociedad Española de Medicina e Ingeniería Tisular SEMIT Reconocido por su experiencia y liderazgo en este campo, el Dr. Ordoño compartirá las últimas técnicas y avances en ingeniería tisular, con un enfoque en aplicaciones reales que ya están revolucionando el tratamiento de lesiones en el aparato locomotor. 👨⚕️ Moderador: Dr. Dr Ignacio Dallo una de las figuras más influyentes en medicina regenerativa en España y profesor de la AEMR, quien guiará este webinario garantizando un diálogo enriquecedor y dinámico. ✨ ¿Por qué asistir? Descubre cómo los avances en ingeniería tisular están transformando el tratamiento de lesiones del aparato locomotor. Aprende aplicaciones prácticas para integrar en tu propia práctica médica. Interactúa con expertos en medicina regenerativa y resuelve tus dudas en directo. ¡Únete a nosotros en este viaje hacia el futuro de la regeneración y reparación de tejidos! La ingeniería tisular aplicada al aparato locomotor está aquí para quedarse, y este webinario es la oportunidad perfecta para profundizar en sus posibilidades. 🔗 Regístrate ahora y asegura tu lugar en este evento clave para el avance de tu práctica clínica. https://lnkd.in/d6-E2suh
This is an excellent #mesenchymalstemcells special study group in Italy! Vet Stem Cell Hub strongly supports this collaboration.
Veterinary Orthopaedic Surgeon, Advanced Practitioner in Small Animal Orthopaedics, MSc in Stem Cells and Regeneration, MSc in Orthopaedic Engineering, VOA Podcast host, International Speaker.
Thank you Gruppo Italiano Staminali Mesenchimali for inviting me to co-present at yesterday's meeting with Claire Hawkes on #canine 🐕 and #equine 🐴 #stemcell therapies. It was a very informative session. Special shout out to Ana Ivanovska for hosting the event in Italian and English. #regenerativemedicine #singapore
Vet Stem Cell Hub we fully support The Zero Pain Philosophy !
Veterinary Orthopaedic Surgeon, Advanced Practitioner in Small Animal Orthopaedics, MSc in Stem Cells and Regeneration, MSc in Orthopaedic Engineering, VOA Podcast host, International Speaker.
Congratulations Mount Pleasant Veterinary Group - Singapore, Jalan Gelenggang, on being awarded the prestigious The Zero Pain Philosophy Practice Accreditation. This verifies that the latest, most effective, #analgesia practices are integral to our everyday patient care. Well done the entire team. ⭐ Another milestone for Mount Pleasant: first practice in South East Asia to achieve this standard! ⭐ #vettech #vetnurse #abetterworldforpets #veterinarian #singapore #marsVHAsia Matthew Gurney Carl Bradbrook Bret Benjamin Tom Fitzsimons Sam Alexander Guo Michelle Laborde, RVT
⭐️⭐️⭐️⭐️⭐️ brilliant achievement #vet #osteoarthitis alliance. Vet Stem Cell Hub supports your efforts to improve the lives of animals worldwide🌍🐾🐴.
The Veterinary Osteoarthritis Alliance Celebrates Membership Milestone 🎉 The Veterinary Osteoarthritis Alliance is thrilled to celebrate a major milestone - reaching 450+ members! This achievement highlights the trust and dedication of veterinary professionals who have chosen to join our alliance. As we expand, we remain committed to supporting our members with valuable resources, professional development opportunities, and a collaborative network to enhance veterinary osteoarthritis care. Greg McGarrell, CEO of Nupsala and VOA director, says, “We would like to thank our industry partners, Animalcare UK Ltd, Lintbells Veterinary, Nupsala Chanelle Pharma, and Vetoquinol UK Ltd, for their unwavering support in helping us reach this milestone. Your collaboration and dedication have been integral to our success, and together, we have achieved remarkable progress in advancing veterinary osteoarthritis care.”
Vet Stem Cell Hub reposted this
BioInformant.com, World's Largest Publisher of Stem Cell Industry News | Real Estate & Bitcoin Investor | Patriot Holdings, Advisor | Former USA Rugby Player 🏉
Stemcyte First Biotech to Receive FDA Approval of a Cord Blood Derived Cellular Therapeutic - https://lnkd.in/gWe8xJps FDA Grants Approval to StemCyte for REGENECYTE™ Cord Blood Cell Therapy StemCyte Inc., a subsidiary of StemCyte International Ltd., has achieved a landmark in regenerative medicine with the U.S. Food and Drug Administration’s (FDA) approval of its Biologics License Application (BLA) for REGENECYTE™. Announced on November 22, 2024, this cord blood derived cellular therapeutic is designed to treat patients with blood and immune system disorders, making StemCyte the first commercial biotech company to receive a biologics license for a cord blood stem cell therapy. Derived from human umbilical cord blood, REGENECYTE™ is an allogeneic hematopoietic stem cell therapy. It has been approved by the U.S. FDA for unrelated donor hematopoietic progenitor cell transplants in patients undergoing preparative regimens for disorders of the hematopoietic system, whether inherited, acquired, or due to myeloablative treatments. This approval makes REGENECYTE™ the 9th cord blood therapy product endorsed by the FDA. Previous approvals of cord blood derived cellular therapeutics include: 1. Allocord: Developed by SSM Cardinal Glennon Children’s Medical Center 2. Clevecord: Developed by Cleveland Cord Blood Center 3. Ducord: Developed by Duke University School of Medicine 4. Hemacord: Developed by New York Blood Center 5. HPC, Cord Blood: Developed by Clinimmune Labs at the University of Colorado 6. HPC, Cord Blood – MD Anderson Cord Blood Bank: Developed by MD Anderson Cancer Center 7. HPC, Cord Blood – LifeSouth: Developed by LifeSouth Community Blood Centers 8. HPC, Cord Blood – Bloodworks: Developed by Bloodworks “StemCyte possesses one of the world’s largest inventories of cord blood stem cells,” remarked Dr. Tong-Young Lee, CEO of StemCyte. “Our mission is to innovate therapies, sustain growth through diverse strategies, and establish ourselves as global leaders in cell therapy.”
Vet Stem Cell Hub reposted this
ICYMI: How Stem Cells Stay Young. (via The Scientist) https://lnkd.in/eXnXcy_g